ARROWHEAD PHARMACEUTICALS, INC. (ARWR) › Weighted Average Diluted SharesARROWHEAD PHARMACEUTICALS, INC. (ARWR) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2010-09-30: 6.43M2011-09-30: 7.83M2017-09-30: 73.90M2018-09-30: 83.64M2019-09-30: 98.61M2020-09-30: 100.72M2021-09-30: 103.75M2022-09-30: 105.43M2023-09-30: 106.75M2024-09-30: 119.78M2025-09-30: 133.76M133.76M2010-09-30Weighted Average Diluted Shares (shares)2025-09-30Period endedWeighted Average Diluted SharesChange YoYSource filing2025-09-30133.76M+11.7%2025-11-25From 2024-10-012024-09-30119.78M+12.2%2025-11-25From 2023-10-012023-09-30106.75M+1.3%2025-11-25From 2022-10-012022-09-30105.43M+1.6%2024-11-26From 2021-10-012021-09-30103.75M+3.0%2023-11-29From 2020-10-012020-09-30100.72M+2.1%2022-11-28From 2019-10-012019-09-3098.61M+17.9%2021-11-22From 2018-10-012018-09-3083.64M+13.2%2020-11-23From 2017-10-012017-09-3073.90M—2019-11-25From 2016-10-012011-09-307.83M+21.7%2011-12-20From 2010-10-012010-09-306.43M—2011-12-20From 2009-10-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)